Kinetics of porphyrin fluorescence accumulation in pediatric brain tumor cells incubated in 5-aminolevulinic acid

Michael Schwake(University Hospital Münster), Christian Ewelt(University of Münster), Dennis Günes(University Hospital Münster), Marc Hotfilder(University Hospital Münster), Walter Stummer(University of Münster), Michael Fruehwald(University Hospital Augsburg), Michaela Köchling(University Hospital Münster), Angela Brentrup(University Hospital Münster), Juliane Schroeteler(University Hospital Münster)
Acta Neurochirurgica
April 28, 2014
10.1007/s00701-014-2096-7
Cited by 21

Related Papers

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k
Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients
|Journal of neurosurgery|2000|880
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
|The Lancet|2019|581
What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?
|Neurosurgery|2015|368